Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge.

PLoS Pathog · 2011 · PMC3197588 · PMID 22028652

Europe PMC DOI

hedged sentences

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

did not reach statistical significancep = 0.065so close (0.05 < p ≤ 0.1)

Animals that received combined VRP-gp350, VRP-EBNA-3A, and VRP-EBNA-3B had an increase in the percentage of rhesus LCV LCL-specific CD8 T cells after vaccination, but the difference did not reach statistical significance (p = 0.065 by T-test).

also in 111,027 other papers

showed a trendno p-value reported

Vaccinia virus expressing gp350 induced EBV neutralizing antibody in seronegative children and a showed a trend toward protection from EBV infection [9] .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.